| Proteomics and syndrome of Chinese medicine. | |
| | |
MedLine Citation:
|
PMID: 20874721 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
Syndrome of Chinese medicine is an understanding of the regularity of disease occurrence and development and its performance of symptoms. Syndrome is the key to recognize diseases and the foundation to treat them. However, because of the complexity of the concept and the limitation of present investigations, the research of syndrome is hard to go further. Proteomics has been received extensive attention in the area of medical diagnosis and drug development. In the holistic and systemic context, proteomics have a convergence with traditional Chinese medicine (TCM) syndrome, which could overcome the one-sidedness and singleness of TCM and avoid the complication and tedious processes. Chinese medicine has a wealth of experience and proteomics has a substantial research potential, the integration of the two aspects will bring a great enhancement of our knowledge of disease. |
| | |
Authors:
|
Chuan-Li Lu; Xiao-Ying Qv; Jian-Guo Jiang |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Journal of cellular and molecular medicine Volume: 14 ISSN: 1582-4934 ISO Abbreviation: J. Cell. Mol. Med. Publication Date: 2010 Dec |
Date Detail:
|
Created Date: 2010-12-07 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101083777 Medline TA: J Cell Mol Med Country: England |
Other Details:
|
Languages: eng Pagination: 2721-8 Citation Subset: IM |
Copyright Information:
|
© 2010 The Authors Journal compilation © 2010 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd. |
Affiliation:
|
College of Food and Bioengineering, South China University of Technology, Guangzhou, China. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Cancer chemotherapy induces cardiotoxicity by targeting cardiac stem cells.
Next Document: Protective effects of AMP-activated protein kinase in the cardiovascular system.